Evaluation of DNA methylation in the human genome: Why examine it and what method to use

European Journal of Gynaecological Oncology

Volumn 25, Issue 1, 2004, Pages 19-24

  Geisler, J P ^a,c   Manahan, K J ^a   Geisler, H E ^b  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b St Vincent Hospital   (United States)

^c Indiana Gynecologic Oncology   (United States)

Author keywords

CpG; Methylation; Mutation; Tumor suppressor genes

Indexed keywords

5 METHYLCYTOSINE; BISULFITE; CYTOSINE; DNA; RESTRICTION ENDONUCLEASE; URACIL;

CARCINOGENESIS; CHEMICAL MODIFICATION; CPG ISLAND; DNA HELIX; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; GYNECOLOGIC CANCER; HUMAN GENOME; MUTATION; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION SITE; REVIEW;

DNA METHYLATION; DNA RESTRICTION ENZYMES; FEMALE; GENETIC TECHNIQUES; GENITAL NEOPLASMS, FEMALE; GENOME, HUMAN; HUMANS; POLYMERASE CHAIN REACTION; SULFITES;

EID: 0842328495     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Hotchkiss R. D. J. Biol. Chem., 1948, 168, 315.
2. Clark S. J., Harrison J., Paul C. L.: "Frommer M. High sensitivity mapping of methylated cytosines". Nuc. Acid. Res., 1994, 22, 2990.
3. Ehrlich M., Gama-Sosa M. A., Huang L. H., Midgett R. M., Kuo K. C., McCune R. A., Gehrke C.: "Amount and distribution of 5-methylcytosine in human DNA from different types of cells". Nucleic Acids Res., 1982, 10, 2709.
4. Momparler R. L., Bovenzi V.: "DNA methylation and cancer". J. Cell. Physiol., 2000, 183, 145.
5. Neumann B., Barlow D. P.: "Multiple roles for DNA methylation in gametic imprinting". Curr. Opin. Genet. Develop., 1996, 6, 159.
6. Barlow D. P.: "Gametic imprinting in mammals". Science, 1995, 270, 1610.
7. Robertson K. D., Jones P. A.: "DNA methylation: past, present and future directions". Carcinogenesis, 2000, 21, 461.
8. Kubota T., Nonoyama S., Tonoki H., Masumo M., Imaizumi Kojima M., Wakui K. et al.: "A new assay for the analysis of X-chromosome inactivation based on methylation-specific PCR". Hum. Genet. 1999, 104, 49.
9. Toyota M., Issa J. P. J.: "The role of DNA hypermethylation in human neoplasia". Electrophoresis, 2000, 21, 329.
10. Rideout W. M. I., Coetzee G. A., Olumi A. F., Jones P. A.: "5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes". Science, 1990, 249, 1288.
11. Mathur P., Xu J., Dedon P. C.: "Cytosine methylation enhances DNA damage produced by groove binding and intercalating enediynes: studies with experamicins A1 and C". Biochemistry, 1997, 36, 14868.
12. Lou W., Krill D., Dhir R., Becich M. J., Dong J. T., Frierson H. F. et al.: "Methylation of the CD44 metastasis suppressor gene in human prostate cancer". Cancer Res., 1999, 59, 2329.
13. Tang X., Khuri F. R., Lee J. J., Kemp B. L., Liu D., Hong W. K., Mao L.: "Hypermethylation of death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer". J. Natl. Cancer Inst., 200, 92, 1511.
14. Domann F. E., Rice J. C., Hendrix M. J. C., Futscher B. W.: "Epigenetic silencing of maspin gene expression in juman breast cancers". Int. J. Cancer, 2000, 85, 805.
15. Baylin S. B., Herman J. G., Graff J. R., Vertino P. M., Issa J. P.: "Alterations in DNA methylation: a fundamental aspect of neoplasia". Adv Cancer Res., 1998, 72, 141.
16. ink4a promoter hypermethylation, p53 mutation, and K-ras mutation in exfoliative material mark the development of lung cancer on symptomatic chronic smokers". J. Clin. Oncol., 2000, 18, 3221.
17. Saluz H., Jost J. P.: "A simple high-resolution procedure to study DNA methylation an in vivo DBA-protien interaction on a single-copy gene level in higher eukaryotes". Proc. Natl. Acad. Sciences, 1989, 86, 2602.
18. Thomassin H., Oakeley E. J., Grange T: "Identification of 5-methylcytosine in complex genomes". Methods, 1999, 19, 465.
19. Herman J. G., Graff J., Myohanen S., Nelkin B. D., Baylin S. B.: "Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands". Proc. Natl. Acad. Sci. USA, 1996, 93, 9821.
20. Tremblay K. D., Saam J. R., Ingram R. S., Tilgham S. M., Bartolomei M. S.: "A paternal-specific methylation imprint marks the alleles of the mouse H19 gene". Nat. Genetics, 1995, 9, 407.
21. Stoger R., Kubicka P., Liu C. G., Kafri T., Razin A., Cedar H., Barlow D. P.: "Maternal-specific methylation of the imprinted mouse Igf2r locus identifies the expressed locus as carrying the imprinting signal". Cell, 1993, 73, 1827.
22. Aggerholm A., Hokland P., Guldberg P.: "DAP-kinase CpG island methylation in acute myeloid leukemia: methodology vs. biology?". Blood, 2000, 95, 2997.
23. Zhang X., Huang C. J., Nazarian R., Ritchie T., de Vellis J. S., Noble E. P.: "Use of a single sequencing termination reaction to distinguish between cytosine and 5-methylcytosine in bisulfite-modified DNA". Biotechniques, 1997, 22, 850.
24. Aggerholm A., Guldberg P., Hokland M., Hokland P.: "Extensive intr- and interindividual heterogeneity of p15INK4B methylation in acute myeloid leukemia". Cancer Res., 1999, 59, 436.
25. Katzenellenbogen R. A., Baylin S. B., Herman J. G.: " Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies". Blood, 1999, 93, 4347.
26. Herman J. G.: "DAP-kinase methylation: methodology and biology". Blood, 2000, 95, 2998.
27. Boyes J., Bird A.: "Repression of genes by DNA methylation depends on CpG density and promoter strenght: evidense for involvement of methyl-CpG binding". EMBO J., 1992, 11, 327.
28. Herman J. G., Umar A., Polyak K., Graff J. R., Ahuja N., Issa J. P. J. et al.: "Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma". Proc. Natl. Acad. Sci. USA, 1998, 95, 6870.
29. Yanagisawa Y., Akiyama Y., Iida S., Ito E., Nomizu T., Sugihara K. et al.: "Methylation of the hMLH1 promoter in familial gastric cancer with microsatellite instability". Int. J. Cancer, 2000, 85, 50.
30. Esteller M., Silva J. M., Dominguez G., Bonilla F., Matias-Guiu X., Lerma E. et al.: "Promoter hypermethylation and BRCA1 inactivation and sporadic breast and ovarian tumors". J. Natl. Cancer Inst., 2000, 92, 564.
31. Geisler J. P., Hatterman-Zogg M. A., Rathe J. A., Buller R. E.: "BRCA1 dysfunction is common in ovarian cancer". J. Natl. Cancer Inst., 2002, 94, 61
32. Hilton J. L., Geisler J. P., Rathe J. A., Hattermann-Zogg M. A., De Young B., Buller R. E.: "Inactivation of BRCA1 and BRCA2 in ovarian cancer". J. Natl. Cancer Inst., 2002, 94, 1396.
33. Geisler J. P., Sood A. L., Holmes R. J., Hatterman-Zogg M. A., Rathe J. A., Buller R. E.: "Mismatch repair gene expression defects contribute to microsatellite instability in ovarian cancer". Cancer (in press), 2003.
34. Baylin S. B., Herman J. G.: "DNA hypermethylation in tumorigenesis: epigenetics joins genetics". Trends Genet., 2000, 16, 168.
35. Newell-Price J., Clark A. J. L., King P.: "DNA methylation and silencing of gene expression". Trends Endocrinol. Metabol., 2000, 11, 142.
36. Fleisher A. S., Esteller M., Wang S., Tamura G., Suzuki H., Yin J. et al.: "Hypermethylation of the hMLH1 gene promoter in juman gastric cancers with microsatellite instability". Cancer Res., 1999, 59, 1090.